Q & M Dental Group (Singapore) Limited

QC7.SI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QC7.SI stands at 308.40M. In comparison, Q0F.SI has a market cap of 18.79B. Regarding current trading prices, QC7.SI is priced at $0.33, while Q0F.SI trades at $2.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QC7.SI currently has a P/E ratio of 16.25, whereas Q0F.SI's P/E ratio is 23.67. In terms of profitability, QC7.SI's ROE is +0.14%, compared to Q0F.SI's ROE of N/A. Regarding short-term risk, QC7.SI is more volatile compared to Q0F.SI. This indicates potentially higher risk in terms of short-term price fluctuations for QC7.SI.

QC7.SI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QC7.SI stands at 308.40M. In comparison, BSL.SI has a market cap of 1.86B. Regarding current trading prices, QC7.SI is priced at $0.33, while BSL.SI trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QC7.SI currently has a P/E ratio of 16.25, whereas BSL.SI's P/E ratio is 33.33. In terms of profitability, QC7.SI's ROE is +0.14%, compared to BSL.SI's ROE of +0.04%. Regarding short-term risk, QC7.SI is more volatile compared to BSL.SI. This indicates potentially higher risk in terms of short-term price fluctuations for QC7.SI.

QC7.SI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QC7.SI stands at 308.40M. In comparison, 9G2.SI has a market cap of 32.92M. Regarding current trading prices, QC7.SI is priced at $0.33, while 9G2.SI trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QC7.SI currently has a P/E ratio of 16.25, whereas 9G2.SI's P/E ratio is -1.03. In terms of profitability, QC7.SI's ROE is +0.14%, compared to 9G2.SI's ROE of -0.38%. Regarding short-term risk, QC7.SI is more volatile compared to 9G2.SI. This indicates potentially higher risk in terms of short-term price fluctuations for QC7.SI.